in Newswire Published on June 23, 2020

Chembio Diagnostics Hit with Class Action After FDA Pulls Emergency Use Permission For COVID-19 Antibody Test

Chernysh v. Chembio Diagnostics, Inc. et al.

Filed: June 18, 2020 § 2:20-cv-02706

Chembio Diagnostics faces a class action centered on the FDA's revocation of an emergency use authorization for the company's COVID-19 antibody test.

Case Spotlight

Hair Relaxer Lawsuits

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on June 23, 2020 — 9:53 AM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.